Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-17

Clinical Trial Update: Rifampin and Efavirenz Interactions in Older Children

View source ↗

Summary

A clinical trial update about potential interactions between rifampin and efavirenz in older children, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)
  • RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: The Miriam Hospital | Conditions: HIV, Tuberculosis | Status: UNKNOWN